Skip to content
DataLookout
Menu

ANAMEKNCT03182491

Mechanisms of Anaphylaxis

StatusActive, Not Recruiting
PhaseNot specified
Primary completion (estimated)

At risk: Primary completion moved at least 2 years 2 months later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 7 versions: 4 with changes below, 3 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Notable Primary and study completion pushed from Oct 1, 2026 to Dec 31, 2028
    • Eligibility criteria expanded, about 4 words
    • Trial status changed: Unknown → Active, Not Recruiting
  2. Minor Changed Registry marked status Unknown; last known: Active, Not Recruiting
  3. Notable Primary and study completion dates pushed to Oct 1, 2026v5
  4. Notable Primary completion date: Oct 2018 to Dec 2019
    • Trial status: Recruiting to Active, Not Recruiting
    • Study completion date: Dec 2018 to Jun 2020
    • Site details revised
    v4
  5. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Clarify mechanisms for anaphylaxis and establish biomarkers for this syndrome
Timeframe: 2 days

Arms and interventions

Anaphylaxis
Febrile transfusion reactions
Mild allergic reactions
Healthy controls

Diagnostic tests: Biomarkers (platelet activating factor [PAF], anaphylatoxins) and basophil activation test (BAT)

Sites

1 site in 1 country

  • Haukeland University HospitalBergen, Norway